ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1708

Unveiling the Uterine-Joint Axis: Dysbiosis and Subclinical Uterine Inflammation in Female Axial Spondyloarthritis Pathogenesis

Daniele Mauro1, Matteo Vecellio2, Anne-Sophie Bergot3, Eva Schmid4, Giulio Forte5, Alessia Stingo6, Alessia Salzillo5, Aldo Pastore7, Paolo Aretini7, Francesca Di Lorenzo7, Antonio ciancio5, Ilenia Pantano5, Gabriele Saccone8, Fulvio Zullo9, carlo Maurizio Montecucco10, Aroldo Rizzo11, Georg Schett12, Ranjeny Thomas13, Mario Zaiss14 and Francesco Ciccia15, 1University of Campania, Italy, Naples, Naples, Italy, 2Fondazione Pisana per la Scienza ONLUS, Pisa, Italy, 3Frazer Institute, University of Queensland, Brisbane, Australia, 4Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Rheumatology and Immunology, Erlangen, Erlangen, Germany, 5University of Campania L. Vanvitelli, Naples, Italy, 6University of Campania L. Vanvitelli, Nasples, Italy, 7Fondazione Pisana per la Scienza ONLUS, Giuliano Terme, Italy, 8University Federico II of Naples, Naples, Italy, 9University of Catanzaro, Catanzaro, Italy, 10Unit of Rheumatology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy, 11Azienda Ospedaliera Ospedali riuniti Villa Sofia Cervello,, Palermo, Italy, 12Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, 13University of Queensland, Brisbane, Australia, 14Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universittsklinikum Erlangen, Erlangen, Germany; 2 Deutsches Zentrum für Immuntherapie (DZI), Erlangen, Germany, 15Università degli studi della Campania Luigi Vanvitelli, Naples, Italy

Meeting: ACR Convergence 2024

Keywords: gender, microbiome, spondyloarthritis, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Abstracts: SpA Including PsA – Basic Science

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Numerous studies exploring gender differences in axial spondyloarthritis (AxSpA) have noted that women exhibit distinct disease manifestations. Yet, a definitive pathophysiological distinction of these diverse immune responses remains elusive thus far, necessitating an investigation into sex-specific pathogenesis. The female genital immune system, a plausible pathogenetic candidate, remains underexplored in AxSpA research. Recent animal models’ data suggest a potential interplay between the uterus and joints. This study aims to investigate a uterine-joint axis in female AxSpA patients, exploring the role of genital tract dysbiosis and subclinical uterine inflammation in disease pathogenesis and elucidating sex differences in AxSpA development.

Methods: Vaginal, cervical, and uterine swabs were collected from 25 premenopausal, newly diagnosed AxSpA patients and 25 age-matched healthy controls (HC). The microbial composition was analyzed using 16S rRNA sequencing. The presence of genital inflammation was investigated in two arthritis models, SKG by histological assessments, flow cytometry and bulk RNAseq. The inflammation and immunological response in human AxSpA uterine tissue was investigated by performing single-cell RNA sequencing on menstrual blood samples from AxSpA patients (n=3) and HC (n=3). This approach mirrors the cellular and immunological composition of uterine tissue.

Results: Microbiota analysis at vaginal, cervical, and uterine levels revealed distinct clustering of patients and controls, indicating different microbiota compositions. This study revealed significant genital dysbiosis in AxSpA patients, marked by reduced lactobacilli and increased, among others, Gardnerella vaginalis (83% in AxSpA vs. 16% in HC; p < 0.001). Figure 1.

In SKG genital inflammation was notably more pronounced at 1 week post-curdlan, with inflammatory infiltrates, microabscesses, and squamous metaplasia (p < 0.001). Bulk RNA sequencing identified specific gene clusters differentiating curdlan-treated mice from controls, revealing upregulated inflammatory pathways. Flow cytometric analysis of SKG genital tract tissues post-curdlan showed a trend towards reduced monocyte/macrophage populations. Additionally, cervix weight and T-cell infiltration were increased in SKG mice compared to BALB/c mice.

Single-cell RNA sequencing of menstrual blood from AxSpA patients revealed a strong imbalance of monocytes and IL7R+ cells compared to HCs (Figure 2), alongside significant differential gene expression. The reduction in genital monocyte observed in human SpA and recapitulated in animal models may successful the egression and migration of these cells from the genital tract.

Conclusion: This study demonstrates genital tract dysbiosis and distinct immune cell profiles in female AxSpA patients for the first time, revealing a potential uterine-joint axis involved in the disease’s pathogenesis. This multimodal genomic and molecular approach provides new insights into the cervicovaginal microbiota, immune landscape, and AxSpA, emphasizing the need for further exploration of sex differences in rheumatic diseases.

Supporting image 1

Figure 2. Cell profiling of SpA and HC of uterine tissue by scRNA sequencing on menstrual blood

Supporting image 2

Figure 1. Summary of the differentially abundant microbial species in the cervix of SpA patients vs HC.


Disclosures: D. Mauro: AstraZeneca, 1, 6, GlaxoSmithKlein(GSK), 6, Janssen, 6, Novartis, 6, UCB, 6; M. Vecellio: None; A. Bergot: None; E. Schmid: None; G. Forte: None; A. Stingo: None; A. Salzillo: None; A. Pastore: None; P. Aretini: None; F. Di Lorenzo: None; A. ciancio: None; I. Pantano: None; G. Saccone: None; F. Zullo: None; c. Montecucco: None; A. Rizzo: None; G. Schett: Bristol-Myers Squibb(BMS), 6, Cabaletta, 6, Janssen, 6, Kyverna Therapeutics, 6, Novartis, 6; R. Thomas: AbbVie/Abbott, 2, CSL, 2, 5; M. Zaiss: None; F. Ciccia: AbbVie, 1, 2, 6, Galapagos, 1, 2, 6, Janssen, 1, 2, 6, Lilly, 1, 2, 6, Novartis, 1, 2, 6, UCB, 1, 2, 6.

To cite this abstract in AMA style:

Mauro D, Vecellio M, Bergot A, Schmid E, Forte G, Stingo A, Salzillo A, Pastore A, Aretini P, Di Lorenzo F, ciancio A, Pantano I, Saccone G, Zullo F, Montecucco c, Rizzo A, Schett G, Thomas R, Zaiss M, Ciccia F. Unveiling the Uterine-Joint Axis: Dysbiosis and Subclinical Uterine Inflammation in Female Axial Spondyloarthritis Pathogenesis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/unveiling-the-uterine-joint-axis-dysbiosis-and-subclinical-uterine-inflammation-in-female-axial-spondyloarthritis-pathogenesis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/unveiling-the-uterine-joint-axis-dysbiosis-and-subclinical-uterine-inflammation-in-female-axial-spondyloarthritis-pathogenesis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology